申请人:D. E. Shaw Research, LLC
公开号:US20220411367A1
公开(公告)日:2022-12-29
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.